Healthspan
Search documents
How I Learned to Prescribe Motivation to my Patients | Jordan Metzl | TEDxBoston
TEDx Talks· 2026-03-05 17:03
Now, I'm a sports medicine doctor down at Hospital for Special Surgery in New York City. And during the day, I take care of people's aches and pains of all across their body. But in the evenings and weekends, I've uh built a whole exercise prescription around getting people moving.And the title of my talk today is how I learned to prescribe motivation through exercise to my patients for healthy longevity. Because we've heard a lot of different things of getting people to reverse aging and live longer. But t ...
Niagen Bioscience (NasdaqCM:CDXC) FY Conference Transcript
2026-01-15 17:32
Summary of Niagen Bioscience FY Conference Call Company Overview - Niagen Bioscience, formerly known as ChromaDex, focuses on nicotinamide riboside (NR), a precursor to the coenzyme NAD (nicotinamide adenine dinucleotide) [2][3] - The company has over 100 patents related to NAD precursors and has conducted 41 clinical studies and over 100 preclinical studies on Niagen [4] Core Product and Market Position - Niagen is positioned as the leading product in the NAD supplement space, with claims of improving cellular resilience and healthspan, particularly in aging populations [3][10] - The company has diversified its offerings, selling Niagen as a dietary supplement, a B2B ingredient, and as an injectable product [5][13] Financial Performance - Niagen Bioscience reported approximately $125 million in revenue and $20 million in net income over the last 12 months, with a strong balance sheet showing nearly $65 million in cash and no debt [20] - The company operates conservatively, focusing on maintaining a strong cash position and exploring growth opportunities [28] Growth Opportunities - The NAD IV market is rapidly growing, potentially surpassing the supplement market, with initial retail sales estimated between $50-$100 million in the first year [24][23] - Plans to launch a telehealth business for at-home injections are expected to cater to the growing interest in self-administered health products [15] Research and Development - Niagen Bioscience emphasizes R&D, investing significantly in understanding its products and their effects, with a commitment to quality science [18] - The company is exploring applications in orphan diseases, particularly those that cause rapid aging in children, with promising results from clinical studies [16] Skincare Market Potential - The company is pursuing opportunities in the skincare market, leveraging niacinamide, which elevates NAD but is less effective than NR [17] - Discussions with major global skincare companies are ongoing, with expectations for announcements in 2026 [18] Strategic Partnerships - Niagen has formed partnerships with networks of healthcare practitioners to educate consumers and promote its products [26] - The company aims to differentiate itself through scientific credibility and informed marketing strategies [27] Market Challenges - The company faces challenges from competitors and infringers in the NAD space, which can impact sales and market perception [22] - The stock has shown volatility, attributed to external market factors rather than company performance [20] Conclusion - Niagen Bioscience is well-positioned in the growing NAD market, with a strong financial foundation and diverse product offerings. The company is focused on expanding its market presence through innovative products, strategic partnerships, and a commitment to research and development [20][28]
The role of mindset, purpose, and relationships in longevity | Barbara Waxman | TEDxBoston
TEDx Talks· 2025-12-22 15:04
I have a confession to make. When I pick up a newspaper, the first thing I do is flip straight to the obituaries. That's right, the obits.It's not because I'm morbid, and it's not because I've been a gerontologist since the field was in its infancy. It's because obituaries are the true highlight reels of our lives. In just a few paragraphs, you see what truly mattered.The passions, the quirks, the loves lost and gained, the impact, the risks taken or not. They're a masterclass in what it takes to live, not ...
How persistent pathogens could accelerate the aging process | Amy Proal | TEDxBoston
TEDx Talks· 2025-11-21 17:02
Core Argument - The prevailing aging models inadequately address the role of persistent pathogens (viruses, bacteria, parasites) as a significant driver of human aging and healthspan reduction [1] - Persistent pathogens can embed themselves in tissues and nerves, potentially driving various health problems later in life [2][3][4] - These pathogens can actively distort the signaling of human genes, impacting multiple hallmarks of aging [8] Pathogen Prevalence and Impact - Approximately 95% of individuals harbor one or more strains of herpes virus [5] - Around 11% of people in the US and up to 87% in some global regions carry the chronic parasite toxoplasma [6] - Persistent SARS-CoV-2 virus has been found in tissue samples months or years after initial infection [7] - Pathogens can drive mitochondrial dysfunction by hijacking host cell metabolism [10][11][12] - Viruses can integrate into telomeres, leading to shorter and more unstable telomeres [13][14] - Viral proteins can interact with and distort the signaling of human aging pathways [15] Proposed Solutions and Recommendations - The industry needs to seriously consider the impact of persistent pathogens when developing healthspan extending interventions [17] - Curbing the activity of pathogens should precede interventions like gene editing [18] - Integrating existing antiviral and anti-parasite medications into healthspan protocols is recommended [18] - Individuals with herpes simplex virus who regularly took anti-herpes virus medications had a 10 times lower risk of developing dementia [19] - Investment in new diagnostic test platforms to identify persistent pathogens is crucial [20][21] - Incorporating the activity of persistent pathogens into aging models is essential for successfully extending healthspan [22]
Could AI improve healthcare? | Lara Lewington | TEDxVezins
TEDx Talks· 2025-11-10 17:37
AI在医疗健康领域的应用 - AI与前沿科学和医生合作,推动医疗健康领域发展[2] - AI能够分析生活方式、活动、睡眠、空气质量和疾病发生等数据,从而更好地预测癌症、心脏病和2型糖尿病等疾病[6] - AI可以辅助医生进行扫描,帮助发现肿瘤,并协助医生记录,从而实现更人性化的互动[6][7] - AI可以通过面部微表情和视线模式来量化抑郁症,目前正在英国国民健康服务体系中针对产后妇女进行试验[7] - AI驱动的药物发现和个性化治疗正在兴起,这意味着能够更有效地靶向肿瘤,同时减少对患者的伤害[10][11] 癌症诊断与治疗 - 行业专家认为,AI将在癌症的诊断和治疗方面带来最大的变革,因为癌症存在诸多变量,如肿瘤的遗传学、位置、阶段、患者的遗传学,甚至微生物组[8] - 血液检测将越来越多地用于筛查多种癌症,更有针对性的筛查活动将更早地发现更多癌症,从而可以更好地治疗[9] 数据的重要性 - 数据是AI的燃料,需要高质量、适用且统一[14] - 基因组测序的成本已大幅降低,但关键在于如何利用这些数据[14][15] - Genomics England正在对10万名有患罕见疾病风险的婴儿进行基因组测序,及早发现可以避免失明等情况[16] 可穿戴设备与健康 - 可穿戴设备可以收集大量关于个人的数据,帮助人们了解自身健康状况的基线[17][18] - 可穿戴设备虽然不是医疗设备,但可以帮助人们发现身体模式的变化,从而及早发现健康问题,例如心脏病甚至癌症[19] - 睡眠模式的改变可能在痴呆症症状出现前20到30年就已发生,因此,如果能够识别这些数据中的模式,就有机会采取行动[20] 医疗的最终目标 - 医疗的目标不仅是延长寿命,还要提高生活质量,保持身心健康[24] - AI有潜力将医疗体系从“疾病护理”转变为“健康护理”,并为所有人提供服务[24]
X @Demis Hassabis
Demis Hassabis· 2025-10-11 05:41
RT Eric Topol (@EricTopol)Why does the naked mole rat have the longest lifespan and healthspan of any rodent, nearly 40 years?A 30-year long mystery unraveled @ScienceMagazine today!Its cGAS enzyme in cells has 4 missense mutations that upends its function, promoting DNA repair and suppressing inflammationhttps://t.co/gtkefjgWyi ...
BEYOND IMMORTALITY: European Wellness Biomedical Group Unveils Landmark Research on Longevity Through Cell Regeneration Over Organ Transplants
Globenewswire· 2025-10-02 20:39
Core Insights - The European Wellness Biomedical Group (EWBG) emphasizes that true longevity is achieved through cellular regeneration rather than organ transplantation, focusing on healthspan over lifespan [1][3][17] - Prof. Mike Chan's recent publications include the Human Cytology Atlas, which maps over 400 distinct human cell types, and a study on organ aging, highlighting the varying rates at which different organs age [1][11][24] Company Developments - EWBG has published significant scientific contributions, including the Human Cytology Atlas and a peer-reviewed study on organ aging, reinforcing its position in the field of regenerative medicine [1][10][24] - The company is involved in global collaborations, such as working with the Chinese government on autism therapies and ongoing research with Heidelberg University in Germany and Switzerland [14][24][25] Industry Trends - The conversation around longevity is shifting from organ transplantation to cellular regeneration, with a focus on targeted therapies that address the cellular mechanisms of aging [6][12][17] - Prof. Chan advocates for precision medicine that tailors interventions to individual cellular profiles, aiming to extend healthspan rather than merely increasing lifespan [13][21]
Peloton Pivots to ‘Healthspan' Strategy of Holistic Wellness
PYMNTS.com· 2025-08-07 17:30
Core Insights - Peloton is repositioning itself as a holistic wellness brand, moving beyond cardio fitness to encompass strength, stress management, sleep, and nutrition as part of a broader turnaround strategy aimed at sustainable profitability [2][4][15] Revenue and Cost Management - The company is targeting $100 million in annual savings by fiscal 2026, with half of the savings already achieved through job cuts and the remainder expected from reductions in general and administrative costs, sales and marketing, R&D, and stock-based compensation [12] - For Q4 of fiscal 2025, Peloton reported a net income of $21.6 million, or 5 cents per share, compared to a net loss of $30.5 million, or 8 cents per share, a year earlier, with total revenue at $606.9 million, down 6% from the prior year [13][14] Target Audience and Market Strategy - The company is focusing on the younger generation, whose wellness needs extend beyond traditional cardio exercises, reflecting a shift towards a more comprehensive definition of well-being [15] - Peloton has launched special pricing programs for students, educators, first responders, healthcare workers, and military personnel to broaden accessibility and attract price-sensitive buyers [8] Technological Integration - Advanced technology, including artificial intelligence, will be utilized to deliver personalized coaching and wellness recommendations, integrating data from wearables and other sources [6] - The company aims to transition from a product-led business to one centered on personalized, tech-enabled wellness coaching across various aspects of health [5] Distribution and Community Engagement - Peloton is expanding its distribution channels by opening micro stores and launching a resale platform, Peloton Repowered, allowing customers to buy and sell used equipment [7] - The company is investing in retention and community-building strategies, including gamification and a loyalty rewards program, to enhance long-term user engagement [10]